Literature DB >> 9368065

Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.

R L Mellgren1.   

Abstract

Cell-permeant peptidyl aldehydes and diazomethylketones are frequently utilized as inhibitors of regulatory intracellular proteases. In the present study the specificities of several peptidyl inhibitors for purified human mu-calpain and 20 S proteasome were investigated. Acetyl-LLnL aldehyde, acetyl-LLM aldehyde, carbobenzyloxy-LLnV aldehyde (ZLLnVal), and carbobenzyloxy-LLY-diazomethyl ketone produced half-maximum inhibition of the caseinolytic activity of mu-calpain at concentrations of 1-5 x 10(-7) M. In contrast, only ZLLnVal was a reasonably potent inhibitor of the caseinolytic activity of 20 S proteasome, producing 50% inhibition at 10(-5) M. The other inhibitors were at least 10-fold less potent, producing substantial inhibition only at near saturating concentrations in the assay buffer. Further studies with ZLLnVal demonstrated that its inhibition of the proteasome was independent of casein concentration over a 25-fold range. Proteolysis of calpastatin or lysozyme by the proteasome was half-maximally inhibited by 4 and 22 microM ZLLnVal, respectively. Thus, while other studies have shown that ZLLnVal is a potent inhibitor of the hydrophobic peptidase activity of the proteasome, it appears to be a much weaker inhibitor of its proteinase activity. The ability of the cell permeant peptidyl inhibitors to inhibit growth of the yeast Saccharomyces cerevisiae was studied because this organism expresses proteasome but not calpains. Concentrations of ZLLnVal as high as 200 microM had no detectable effect on growth rates of overnight cultures. However, yeast cell lysates prepared from these cultures contained 2 microM ZLLnVal, an amount which should have been sufficient to fully inhibit hydrophobic peptidase activity of yeast proteasome. Degradation of ubiquitinylated proteins in yeast extracts by endogenous proteasome was likewise sensitive only to high concentrations of ZLLnVal. The higher sensitivity of the proteinase activity of calpains to inhibition by the cell permeant inhibitors suggests that calpain-like activities may be targets of these inhibitors in animal cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368065     DOI: 10.1074/jbc.272.47.29899

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Ligand binding directly stimulates ubiquitination of the inositol 1, 4,5-trisphosphate receptor.

Authors:  C C Zhu; R J Wojcikiewicz
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway.

Authors:  J Oberdorf; J M Webster; C C Zhu; S G Luo; R J Wojcikiewicz
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  Calpain regulates enterocyte brush border actin assembly and pathogenic Escherichia coli-mediated effacement.

Authors:  David A Potter; Anjaiah Srirangam; Kerry A Fiacco; Daniel Brocks; John Hawes; Carter Herndon; Masatoshi Maki; David Acheson; Ira M Herman
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

4.  Effects of phosphatase and proteasome inhibitors on Borealin phosphorylation and degradation.

Authors:  Dipali Date; Megan R Dreier; Michael T Borton; Michael E Bekier; William R Taylor
Journal:  J Biochem       Date:  2012-02-29       Impact factor: 3.387

Review 5.  Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging.

Authors:  Alexei Terman; Tino Kurz; Marian Navratil; Edgar A Arriaga; Ulf T Brunk
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

6.  Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP.

Authors:  Larissa Belova; Sanjay Sharma; Deanna R Brickley; Jeremy R Nicolarsen; Cam Patterson; Suzanne D Conzen
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

7.  O2 enhancement of human trophoblast differentiation and hCYP19 (aromatase) gene expression are mediated by proteasomal degradation of USF1 and USF2.

Authors:  Bing Jiang; Carole R Mendelson
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

8.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.

Authors:  L Meng; R Mohan; B H Kwok; M Elofsson; N Sin; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

9.  Role of proteases in the pathophysiology of cardiac disease.

Authors:  Raja B Singh; Sucheta P Dandekar; Vijayan Elimban; Suresh K Gupta; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

10.  Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia.

Authors:  Ziying Yan; Roman Zak; Yulong Zhang; Wei Ding; Simon Godwin; Keith Munson; Richard Peluso; John F Engelhardt
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.